The Food and Drugs Authority (FDA) of Ghana has declared its intention to appeal a recent High Court ruling in a case involving Tobinco Pharmaceuticals Ltd.
In a statement released, the FDA expressed its disagreement with the court’s decision while affirming its commitment to the judicial process.
“The FDA acknowledges the judgement delivered by the High Court. However, the Authority respectfully disagrees with the decision and intends to exercise its right to appeal”.
The case, which dates back to actions taken in 2013, has been a subject of legal contention since Tobinco Pharmaceuticals initiated proceedings against the FDA in 2019.
In its clarification, the FDA addressed misconceptions surrounding the case, particularly media reports suggesting negligence on the part of its current CEO, Dr. Delese Darko.
“The Food and Drugs Authority (FDA) has noted with concern the manner in which the recent ruling in the case of Tobinco Pharmaceuticals Ltd. vs. The Food and Drugs Authority is being reported in the media”.
“Some media reports suggest that the CEO, Dr Delese Darko has been negligent in her actions thus causing the Authority to suffer this loss.”
The authority emphasized that the case originated during the tenure of former CEO Dr. Stephen Opuni and that the current leadership.
The FDA’s statement reads, “For the avoidance of doubt, the Authority informs the public that this case stems from actions taken in 2013. Despite the claims made against the then CEO, Dr. Stephen Opuni by the applicant, Tobinco Pharmaceuticals Ltd, the current leadership of the organisation have provided a defence to the courts at all material times.”
“The FDA remains committed to upholding the judicial process and adhering to the rule of law, and will follow due process until the matter is fully resolved”.
Click here to read Clarification on Tobinco Pharmaceuticals Ltd. vs. Food and Drugs Authority
Click on the link to join the OnlineTimesGH News channel for curated, meaningful stories tailored just for
YOU:https://whatsapp.com/channel/0029VajF89Q6WaKprDT5mu2V
